ISRCTN95691970已完成未知
Sorafenib combined with percutaneous radio-frequency ablation of both hepatocellular carcinoma nodule and portal vein tumor thrombus compared with sorafenib alone: a western randomized controlled trial
D. Cotugno Hospital0 个研究点目标入组 100 人开始时间: 2016年7月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
2016 results in: https://www.ncbi.nlm.nih.gov/pubmed/27793949
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Child-Pugh A 5-6 liver cirrhosis
- •2. A single HCC nodule < 6.5 cm in diameter and concomitant main portal vein tumor thrombus (MPVTT)
- •3. Maximum 3 HCC nodules with the largest one no more than 5 cm with MPVTT
排除标准
- •1. Patients with ascites
- •2. Patients with bilirubin >2 mg/dl
- •3. Patients and with extrahepatic spread of disease
研究者
相似试验
Unknown
不适用
Combined Radiotherapy and Sorafenib in Patients With HepatomaHepatocellular CarcinomaNCT01319942China Medical University Hospital45
已完成
2 期
Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT StudyAdvanced Hepatocellular CarcinomaNCT05117957Bo Hyun Kim50
已完成
2 期
Intermittent treatment with sorafenib in combination with transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): a randomized open-label phase 2 studyC22.0Liver cell carcinomaDRKS00012551Dekanat des Fachbereichs Medizin Klinikum der Johann Wolfgang Goethe-Universität, Haus 154
已完成
2 期
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma MultiformeGlioblastoma MultiformeNCT00544817SCRI Development Innovations, LLC47
已完成
不适用
Pilot study of sorafenib for RET fusion positive non-small cell lung cancerRET fusion positive non-small cell lung cancerJPRN-UMIN000007515Japanese Foundation for Cancer Research Cancer Institute Hospital3